newsfilter
← Latest News
PR Newswire·

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

LENZ Therapeutics, Inc. (Nasdaq: LENZ or "LENZ" or the "Company"), today announced VIZZ (aceclidine ophthalmic solution) 1.44%, the first and only...